EU HTA Regulation: Companies Can Talk To National Authorities As ‘Substitute’ For EU-Level Advice

Not all companies will be able to access joint scientific consultations under the EU Health Technology Assessment Regulation, but success is still possible for those that engage with national agencies early on, says EUCOPE’s Alexander Natz.